QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,879 signal articles · 532 in last 24h · 106,010 total before filter · latest 45m ago
532last 24h
2491last 7d
491● bullish (7d)
254● bearish (7d)
200publishers
AllMacro168Earnings1551M&A141Regulatory15Product8Analyst22
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Wild Markets Week Settles Down
The Wall Street Journal13d agoneutral
Wild Markets Week Settles Down

TODAY'S MARKETS Billions of dollars of losses in artificial-intelligence stocks. Sharp spikes in oil prices that dropped just as quickly. A jump in benchmark Treasury yields Thursday to their highest level this year.

Photronics (PLAB): Buy, Sell, or Hold Post Q1 Earnings?
StockStory13d agoneutral
Photronics (PLAB): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, Photronics’s shares (currently trading at $30.49) have posted a disappointing 12.1% loss, well below the S&P 500’s 7.9% gain. This was partly due to its softer quarterly results and might have investors contemplating their next move.

2 Reasons to Watch ANIP and 1 to Stay Cautious
StockStory13d agoneutral
2 Reasons to Watch ANIP and 1 to Stay Cautious

Since January 2026, ANI Pharmaceuticals has been in a holding pattern, posting a small loss of 3.5% while floating around $78.49. The stock also fell short of the S&P 500’s 7.9% gain during that period.

3 Reasons WYNN is Risky and 1 Stock to Buy Instead
StockStory13d agobullish
3 Reasons WYNN is Risky and 1 Stock to Buy Instead

Over the past six months, Wynn Resorts’s shares (currently trading at $95.86) have posted a disappointing 16% loss, well below the S&P 500’s 7.9% gain. This might have investors contemplating their next move.

3 Reasons We’re Fans of Natera (NTRA)
StockStory13d agoneutral
3 Reasons We’re Fans of Natera (NTRA)

Natera has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 9.1% to $263.44 per share while the index has gained 7.9%.

3 Reasons to Sell XRAY and 1 Stock to Buy Instead
StockStory13d agoneutral
3 Reasons to Sell XRAY and 1 Stock to Buy Instead

Dentsply Sirona has been treading water for the past six months, recording a small loss of 0.5% while holding steady at $12.66. The stock also fell short of the S&P 500’s 7.9% gain during that period.

3 Reasons We Love Planet Labs (PL)
StockStory13d agoneutral
3 Reasons We Love Planet Labs (PL)

Over the last six months, Planet Labs’s shares have sunk to $22.32, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 7.9% gain. This may have investors wondering how to approach the situation.

3 Big Reasons to Love Riley Exploration Permian (REPX)
StockStory13d agoneutral
3 Big Reasons to Love Riley Exploration Permian (REPX)

Riley Exploration Permian has had an impressive run over the past six months as its shares have beaten the S&P 500 by 23.4%. The stock now trades at $36.04, marking a 31.2% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

UBS Says It’s Time to Diversify — These Are Its 2 Stock Picks
TipRanks13d agoneutral
UBS Says It’s Time to Diversify — These Are Its 2 Stock Picks

Wall Street pulled back on Thursday after the S&P 500 had spent recent weeks trading near record territory. The index fell 1.2%, while the Nasdaq dropped 2.15%, as investors digested disappointing earnings from several large tech companies, heavier AI spending plans, higher oil prices, and rising Treasury yields.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and dis